The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    N. Korea holds politburo meeting to discuss Kim-Putin summit: KCNA

  • 3

    BLACKPINK's contract renewal still in limbo

  • 5

    Kim Jong-un's rejection of Russia's food assistance irritates North Korean defectors

  • 7

    INTERVIEWVirtual K-pop group MAVE: is more than just pretty pixels

  • 9

    Russia lodges protest to S.Korean envoy over Yoon's UN speech

  • 11

    Lawmakers want to grill business tycoons over decision to rejoin FKI

  • 13

    Disney+ aims to expand investment in original Korean content

  • 15

    Appellate court upholds 9-yr prison term for man over filming, distributing sexual videos featuring women

  • 17

    Yoon signs off on plan to waive expressway tolls during Chuseok holiday

  • 19

    JSW in talks with LG Energy Solution to make EV batteries in India: sources

  • 2

    Scientists find green way to turn CO2 into fuel with sunlight

  • 4

    BTS member Suga begins mandatory military service

  • 6

    Opposition party in turmoil as leader could be arrested on Tuesday

  • 8

    Korea boosts subsidies to rev up falling EV sales

  • 10

    Foreign employees rewarded for contribution to Korea's shipbuilding industry

  • 12

    Arrest warrant hearing for DPK leader Lee to be held Tuesday

  • 14

    Korea hammers Thailand to clinch men's football knockout berth

  • 16

    Hebrew University students travel to Korea to explore musical landscape

  • 18

    Gov't reviews changing description of Fukushima wastewater

  • 20

    'Songpyeon' for low-income families

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Sun, September 24, 2023 | 03:19
Tech
Janssen files patent suit against Samsung Bioepis
Posted : 2017-05-21 16:19
Updated : 2017-05-21 17:27
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
By Kang Seung-woo

Janssen Biotech has taken Samsung Bioepis to court in the U.S., accusing the Korean company of violating patents for its top-selling drug. Analysts said Sunday Janssen appeared to be trying to delay a Samsung biosimilar drug's entry into the U.S. market.

In April, Samsung won approval from the U.S. Food and Drug Administration to sell Renflexis -- its biosimilar of Janssen's blockbuster rheumatoid arthritis medicine Remicade. It was expected to go on sale in the world's largest pharmaceutical market late this year.

Samsung Bioepis said Janssen, a subsidy of healthcare conglomerate Johnson & Johnson, filed a lawsuit in the U.S. District Court of New Jersey last week, claiming Samsung has infringed on three of its patents. It also asks for damages. Remicade generates nearly $5 billion (5.59 trillion won) in sales a year.

"Janssen's patent lawsuit is an anticipated step. We will continue to proceed with the U.S. launch of Renflexis as planned," a Samsung official said. "Janssen takes issue with the same patents as it did with Celltrion's Inflectra."

Janssen last year filed a lawsuit against Celltrion, a cross-city rival of Samsung Bioepis, with another Remicade biosimilar named Inflectra. The Patent Trial and Appeal Board ruled in favor of the Korean company, which released the medicine in the U.S. market last November.

Observers expect that the legal action would not delay or prevent the U.S. market launch of the Samsung product, which Merck will take to market in November at the earliest.

Emailksw@ktimes.com Article ListMore articles by this reporter
 
miguel
Top 10 Stories
1Scientists find green way to turn CO2 into fuel with sunlight Scientists find green way to turn CO2 into fuel with sunlight
2Kim Jong-un's rejection of Russia's food assistance irritates North Korean defectors Kim Jong-un's rejection of Russia's food assistance irritates North Korean defectors
3Opposition party in turmoil as leader could be arrested on Tuesday Opposition party in turmoil as leader could be arrested on Tuesday
4Korea boosts subsidies to rev up falling EV sales Korea boosts subsidies to rev up falling EV sales
5Russia lodges protest to S.Korean envoy over Yoon's UN speech Russia lodges protest to S.Korean envoy over Yoon's UN speech
6Foreign employees rewarded for contribution to Korea's shipbuilding industry Foreign employees rewarded for contribution to Korea's shipbuilding industry
7Lawmakers want to grill business tycoons over decision to rejoin FKI Lawmakers want to grill business tycoons over decision to rejoin FKI
8Gov't reviews changing description of Fukushima wastewater Gov't reviews changing description of Fukushima wastewater
9'Songpyeon' for low-income families 'Songpyeon' for low-income families
10Big insurers up for sale, but financial conglomerates appear disinterested Big insurers up for sale, but financial conglomerates appear disinterested
Top 5 Entertainment News
1BLACKPINK's contract renewal still in limbo BLACKPINK's contract renewal still in limbo
2[INTERVIEW] Virtual K-pop group MAVE: is more than just pretty pixels INTERVIEWVirtual K-pop group MAVE: is more than just pretty pixels
3Hebrew University students travel to Korea to explore musical landscape Hebrew University students travel to Korea to explore musical landscape
4[INTERVIEW] Seoul's increased art market momentum brings Sotheby's back to Korea INTERVIEWSeoul's increased art market momentum brings Sotheby's back to Korea
5[INTERVIEW] 'Cobweb' director questions meaning of cinema INTERVIEW'Cobweb' director questions meaning of cinema
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group